soul study semaglutide SOUL: Oral Bests Usual Care in High-Risk Type 2 Diabetes Two-year effects of semaglutide in
Description
oral GLP-1s are finally getting interesting
Methods PIONEER REAL Switzerland was a 3444-week, multicentre, prospective, non-interventional, single-arm study of adults with T2D nave to injectable glucose-lowering medication who were initiated on oral semaglutide in routine clinical practice
Discover why injection-site bruising occurs with Ozempic (semaglutide), how to prevent it with proper technique, and when bruising warrants medical review
Read the release:
Additionally, the safety of these drugs is put into perspective with that of other drugs currently approved for the treatment of PLWO
Clinical trials have
